Cargando…

Clinical outcomes of a genomic screening program for actionable genetic conditions

PURPOSE: Three genetic conditions—hereditary breast and ovarian cancer syndrome, Lynch syndrome, and familial hypercholesterolemia—have tier 1 evidence for interventions that reduce morbidity and mortality, prompting proposals to screen unselected populations for these conditions. We examined the im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buchanan, Adam H., Lester Kirchner, H., Schwartz, Marci L. B., Kelly, Melissa A., Schmidlen, Tara, Jones, Laney K., Hallquist, Miranda L. G., Rocha, Heather, Betts, Megan, Schwiter, Rachel, Butry, Loren, Lazzeri, Amanda L., Frisbie, Lauren R., Rahm, Alanna Kulchak, Hao, Jing, Willard, Huntington F., Martin, Christa L., Ledbetter, David H., Williams, Marc S., Sturm, Amy C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605431/ https://www.ncbi.nlm.nih.gov/pubmed/32601386 http://dx.doi.org/10.1038/s41436-020-0876-4

Ejemplares similares

Generation and Implementation of a Patient-Centered and Patient-Facing Genomic Test Report in the EHR
por: Goehringer, Jessica M., et al.
Publicado: (2018)

A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System
por: Jones, Laney K., et al.
Publicado: (2022)

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment
por: Jones, Laney K., et al.
Publicado: (2020)

Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review
por: Buchanan, Adam Hudson, et al.
Publicado: (2016)

Exome Sequencing–Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants
por: Manickam, Kandamurugu, et al.
Publicado: (2018)

Understanding the Patient Experience of Receiving Clinically Actionable Genetic Results from the MyCode Community Health Initiative, a Population-Based Genomic Screening Initiative
por: Baker, Anna, et al.
Publicado: (2022)

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2023)

Developing Pharmacogenomic Reports: Insights from Patients and Clinicians
por: Jones, Laney K., et al.
Publicado: (2018)

Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program
por: Hao, Jing, et al.
Publicado: (2020)

Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2021)

Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis
por: Jones, Laney K., et al.
Publicado: (2021)

Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H, et al.
Publicado: (2017)

Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H., et al.
Publicado: (2021)

Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents
por: Savatt, Juliann M., et al.
Publicado: (2020)

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study
por: Walters, Nicole L., et al.
Publicado: (2023)

Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results
por: Schmidlen, Tara, et al.
Publicado: (2020)

Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication
por: Campbell-Salome, Gemme, et al.
Publicado: (2022)

Enhancing genomic laboratory reports from the patients' view: A qualitative analysis
por: Stuckey, Heather, et al.
Publicado: (2015)

Enhancing genomic laboratory reports: A qualitative analysis of provider review
por: Williams, Janet L., et al.
Publicado: (2016)

Impact of a Patient-Facing Enhanced Genomic Results Report to Improve Understanding, Engagement, and Communication
por: Williams, Janet L., et al.
Publicado: (2017)

Patient experiences align with the familial hypercholesterolemia global call to action
por: Jones, Laney K., et al.
Publicado: (2022)

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol
por: Jones, Laney K., et al.
Publicado: (2022)

Investigating Psychological Impact after Receiving Genetic Risk Results—A Survey of Participants in a Population Genomic Screening Program
por: McCormick, Cara Zayac, et al.
Publicado: (2022)

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis
por: Jones, Laney K., et al.
Publicado: (2021)

Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories
por: Feigelson, Heather Spencer, et al.
Publicado: (2012)

Economic Evaluation of Universal Lynch Syndrome Screening Protocols among Newly Diagnosed Patients with Colorectal Cancer
por: Hao, Jing, et al.
Publicado: (2021)

Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders
por: Oetjens, M. T., et al.
Publicado: (2019)

Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records
por: Carry, Brendan J., et al.
Publicado: (2021)

A mainstreaming oncogenomics model: improving the identification of Lynch syndrome
por: O’Shea, Rosie, et al.
Publicado: (2023)

Early Outcome Data Assessing Utility of a Post-Test Genomic Counseling Framework for the Scalable Delivery of Precision Health
por: Sturm, Amy C., et al.
Publicado: (2018)

The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives
por: Schmidlen, Tara J., et al.
Publicado: (2022)

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
por: Jones, Laney K., et al.
Publicado: (2021)

Genomic Variation: Lessons Learned from Whole-Genome CNV Analysis
por: Riggs, Erin Rooney, et al.
Publicado: (2014)

Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach
por: Jones, Laney K., et al.
Publicado: (2023)

The Healthcare Systems Research Network (HCSRN) as an Environment for Dissemination and Implementation Research: A Case Study of Developing a Multi-Site Research Study in Precision Medicine
por: Rahm, Alanna Kulchak, et al.
Publicado: (2019)

The Science of Genetics: An Introduction to Heredity. Third Edition
por: Willard, Huntington F.
Publicado: (1978)

Shift happens: family background influences clinical variability in genetic neurodevelopmental disorders
por: Finucane, Brenda, et al.
Publicado: (2016)

Letter to the Editor
por: Frisbie, James H.
Publicado: (2011)

Challenges in Translating GWAS Results to Clinical Care
por: Scheinfeldt, Laura B., et al.
Publicado: (2016)

The Geisinger MyCode Community Health Initiative: an electronic health record-linked biobank for Precision Medicine research
por: Carey, David J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2jnmt57te8e797to50t6tdgf7m